Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
Lars SavendahlTadej BattelinoMichael Højby RasmussenMeryl BrodPaul SaengerReiko HorikawaPublished in: The Journal of clinical endocrinology and metabolism (2022)
This study has been registered at ClinicalTrials.gov, number NCT02616562 (REAL 3).